Foxp3 attenuates cerebral ischemia/reperfusion injury through microRNA-150-5p-modified NCS1
- PMID: 34822811
- DOI: 10.1016/j.yexcr.2021.112942
Foxp3 attenuates cerebral ischemia/reperfusion injury through microRNA-150-5p-modified NCS1
Abstract
Objective: Cerebral ischemia/reperfusion injury (CI/RI) is a pathological process involving complicated molecular mechanisms. We investigated forkhead box P3 (Foxp3)-related mechanism in CI/RI with particular focus on microRNA (miR)-150-5p/nucleobase cation symporter-1 (NCS1) axis.
Methods: A mouse model was constructed by middle cerebral artery occlusion (MCAO) method. Levels of Foxp3, miR-150-5p and NCS1 were assessed in brain tissues of MCAO mice. By determining the neurological behavior function, neurological deficits, brain tissue pathological characteristics, neuronal apoptosis, inflammatory factors, and oxidative stress-related factors, the functional role of Foxp3, miR-150-5p and NCS1 were evaluated in MCAO mice. The feedback loop was analyzed among Foxp3, miR-150-5p and NCS1.
Results: The level of Foxp3 and NCS1 were reduced and that of miR-150-5p was augmented in MCAO mice. Foxp3 bound to miR-150-5p to target NCS1. Up-regulating Foxp3 or NCS1 or suppressing miR-150-5p improved neurological behavior function and neurological deficits, and reduced brain tissue pathological damage, neuronal apoptosis, inflammatory and oxidative stress reactions in MCAO mice. Silencing miR-150-5p or elevating NCS1 decreased Foxp3 silencing-mediated ischemic injury in MCAO mice.
Conclusion: Foxp3 is neuroprotective in CI/RI through binding to miR-150-5p to promote NCS1 expression.
Keywords: Apoptosis; Cerebral ischemia/reperfusion injury; Forkhead box P3; Inflammation; Neurological behavior function; Neurological deficits; Nucleobase cation symporter-1; Oxidative stress; microRNA-150–5p.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare no competing interests.
Similar articles
-
Restored microRNA-326-5p Inhibits Neuronal Apoptosis and Attenuates Mitochondrial Damage via Suppressing STAT3 in Cerebral Ischemia/Reperfusion Injury.Nanoscale Res Lett. 2021 Apr 20;16(1):63. doi: 10.1186/s11671-021-03520-3. Nanoscale Res Lett. 2021. Retraction in: Nanoscale Res Lett. 2022 Dec 9;17(1):120. doi: 10.1186/s11671-022-03766-5. PMID: 33877455 Free PMC article. Retracted.
-
c-myc protects mice from ischemia stroke through elevating microRNA-200b-5p-regulated SIRT1 expression.Brain Res Bull. 2021 Nov;176:76-84. doi: 10.1016/j.brainresbull.2021.07.006. Epub 2021 Aug 8. Brain Res Bull. 2021. PMID: 34371139
-
Exosomal microRNA-150-5p from bone marrow mesenchymal stromal cells mitigates cerebral ischemia/reperfusion injury via targeting toll-like receptor 5.Bioengineered. 2022 Feb;13(2):3030-3043. doi: 10.1080/21655979.2021.2012402. Bioengineered. 2022. PMID: 34898357 Free PMC article.
-
FTX Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress via miR-186-5p/MDM4 Pathway.Neurotox Res. 2022 Apr;40(2):542-552. doi: 10.1007/s12640-022-00485-8. Epub 2022 Mar 28. Neurotox Res. 2022. PMID: 35344194
-
MicroRNA-182-5p attenuates cerebral ischemia-reperfusion injury by targeting Toll-like receptor 4.Biochem Biophys Res Commun. 2018 Nov 2;505(3):677-684. doi: 10.1016/j.bbrc.2018.09.165. Epub 2018 Oct 3. Biochem Biophys Res Commun. 2018. PMID: 30292407
Cited by
-
Liquid Biopsies Poorly miRror Renal Ischemia-Reperfusion Injury.Noncoding RNA. 2023 Apr 1;9(2):24. doi: 10.3390/ncrna9020024. Noncoding RNA. 2023. PMID: 37104006 Free PMC article.
-
Dexmedetomidine ameliorates ischemia-induced nerve injury by up-regulating Sox11 expression.Ann Transl Med. 2023 Feb 15;11(3):153. doi: 10.21037/atm-22-6639. Epub 2023 Feb 10. Ann Transl Med. 2023. PMID: 36846013 Free PMC article.
LinkOut - more resources
Full Text Sources